Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E Adjustments
Ratios

Viking Therapeutics (VKTX) Shares Repurchased (2022)

Viking Therapeutics (VKTX) has disclosed Shares Repurchased for 2 consecutive years, with $1.7 million as the latest value for Q2 2022.

  • Quarterly Shares Repurchased changed N/A to $1.7 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2022, changed N/A year-over-year, with the annual reading at $6.8 million for FY2022, N/A changed from the prior year.
  • Shares Repurchased hit $1.7 million in Q2 2022 for Viking Therapeutics, down from $5.1 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $5.1 million in Q1 2022 to a low of $1.7 million in Q2 2022.